May 13-15, 2010
This will be the second international meeting dedicated to cerebral amyloid angiopathy (CAA) and related brain microvasculopathies, following a previous highly successful meeting (August, 2007) held in Reykjavik, Iceland. All aspects of this unique microvasculopathy will be considered, ranging from molecular/cellular pathogenesis to clinical markers, inheritance, biochemical and neuroimaging biomarkers for CAA, and the role of CAA in dementia, as well as its significance in treatment strategies (e.g. ABeta vaccine). The meeting intends to be a forum for interdisciplinary discussion of 'cutting edge' research on all aspects of CAA in the context of age-related cerebral microvascular disease. As well, CAA will be considered in relation to non-CAA (often hereditary) cerebral microvasculopathies such as CADASIL and cerebroretinal vasculopathies (CRVs).
Download the Flyer
Download the Brochure
Harry V. Vinters, M.D. (UCLA Medical Center, Los Angeles, CA)
Steven M. Greenberg, M.D.,Ph.D. (Massachusetts General Hospital and Harvard Medical School, Boston, MA)
For More Information Contact:
© CAA2009, all rights reserved.